expert report on treatment with tumour-infiltrating lymphocytes (tils)
Published 1 year ago • 1.3K plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
3:16
#esmo22 highlights on tils versus ipilimumab in patients with advanced melanoma: the phase 3 study
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
6:49
expert video report on advances in melanoma clinical research from aacr annual meeting 2021
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
3:41
expert video report on biomarkers for immune checkpoint blockade in patients with solid tumours
-
2:01
tumor infiltrating lymphocytes (tils) as a predictive biomarker in breast cancer
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
6:05
treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved pfs for ...
-
2:15
tumor-infiltrating lymphocytes in advanced melanoma | nejm
-
6:03
#esmo21 expert video report on colorectal cancer
-
9:08
understanding til (tumour-infiltrating lymphocyte) therapy
-
6:02
esmo expert video report on current issues in immuno-oncology
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
2:56
#esmo22 highlights on nirogacestat in patients with progressing desmoid tumours: the defi study
-
45:14
adoptive immunotherapy with tumor-infiltrating t lymphocytes - simon turcotte
-
6:13
lba3 - treatment with tumor-infiltrating lymphocytes versus ipilimumab for advanced melanoma